Poland· PL-100083715
NovoNorm
A repaglinide product containing repaglinidum, registered in Poland by Novo Nordisk A/S. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Repaglinide is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BX02 (repaglinide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Repaglinide · ATC A10BX02
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of repaglinide costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.30 in France to $1.47 in Switzerland — a ×4.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Repaglinide · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.47
- IT Italy$0.39
- FR France$0.30
The record
At a glance
URPL (Poland)- Active substance
- Repaglinidum
- Manufacturer
- Novo Nordisk A/S
- Country
- Poland (PL)
- ATC code
- A10BX02
- ATC class
- Repaglinide
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990804115
- gtin05909990804122
- gtin05909990804139
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
708 interactions on record for repaglinide.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Repaglinide · interactions on record
708 records
- 18 severe
- 502 moderate
- 41 minor
- 145 info
Most severe, free to view
- ClopidogrelB01AC04severe
- GemfibrozilC10AB04severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Repaglinide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENYGLIDKrka, d.d., Novo mesto, Novo mesto
- United KingdomEnyglid 2mg tabletsKrka UK Ltd
- SpainEnyglid 2 mg comprimidos EFGKrka D.D. Novo Mesto
- FranceNOVONORM 2 mg, compriméNOVO NORDISK (DANEMARK)
- ItalyNOVONORMNOVO NORDISK A/S
- FinlandEnyglidKRKA d.d. Novo mesto
- SwedenEnyglid 2 mg TablettKrka d.d., Novo mesto
- NetherlandsEnyglid 2 mg, tabletsKrka d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
- Belgium · Repaglinide Eg
- Bulgaria · Индорин
- Cyprus · Theroflan
- Czechia · Vatinid
- Germany · Repaglinid 1 A Pharma, Repaglinid Abz
- Denmark · Repaglinid Doc Generici
- Spain · Repaglinida Alter, Repaglinida Aurovitas
- Finland · Repaglinid Stada
- France · Repaglinide Arrow Lab, Repaglinide Biogaran
- United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
- Greece · Theroflan
- Croatia · Reglinid, Repaglinid Pharmas
- Iceland · Enyglid, Novonorm
- Italy · Glicam, Repaglinide Aurobindo
- Liechtenstein · Repaglinide Teva
- Luxembourg · Repaglinide Eg
- Latvia · Repaglinide Elvim
- Malta · Repaglinide Aurobindo
- Netherlands · Repaglinide Stada
- Norway · Enyglid, Novonorm
- Romania · Reneos, Repaglinida Arena
- Sweden · Repaglinid Actavis, Repaglinid Stada
- Slovenia · Repaglinid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f40212c7-1e3b-4e5d-8e4c-0f91c2f0da68 GET /v1/drugs/f40212c7-1e3b-4e5d-8e4c-0f91c2f0da68?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "2 mg",
"packaging": "05909990804115 ¦ Rp ¦ EU/1/98/076/018 ¦ 12583\n30 tabl.\n05909990804122 ¦ Rp ¦ EU/1/98/076/019 ¦ 12584\n90 tabl.\n05909990804139 ¦ Rp ¦ EU/1/98/076/020 ¦ 12585\n120 tabl.\nRp ¦ EU/1/98/076/022 ¦ 105334\n270 tabl.\nRp ¦ Skasowane ¦ EU/1/98/076/021 ¦ 105335\n360 tabl.",
"substance": "Repaglinidum 2 mg",
"common_name": "Repaglinidum",
"pl_product_id": "100083715",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about repaglinide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.